Report cover image

Global Dexamethasone Implant Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 187 Pages
SKU # APRC20277549

Description

Summary

According to APO Research, The global Dexamethasone Implant market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dexamethasone Implant is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Dexamethasone Implant is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Dexamethasone Implant is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Dexamethasone Implant is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Dexamethasone Implant include AbbVie, Curia, EyePoint, Ocular Therapeutix, AffaMed Therapeutics and Ocumension Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dexamethasone Implant, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Dexamethasone Implant, also provides the sales of main regions and countries. Of the upcoming market potential for Dexamethasone Implant, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dexamethasone Implant sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Dexamethasone Implant market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Dexamethasone Implant sales, projected growth trends, production technology, application and end-user industry.

Dexamethasone Implant Segment by Company

AbbVie
Curia
EyePoint
Ocular Therapeutix
AffaMed Therapeutics
Ocumension Therapeutics
Dexamethasone Implant Segment by Type

0.7mg
0.35mg
Dexamethasone Implant Segment by Application

Clinic
Hospital
Others
Dexamethasone Implant Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dexamethasone Implant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dexamethasone Implant and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dexamethasone Implant.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dexamethasone Implant market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dexamethasone Implant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dexamethasone Implant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Dexamethasone Implant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

187 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Dexamethasone Implant Market Size, 2020 VS 2024 VS 2031
1.3 Global Dexamethasone Implant Market Size Estimates and Forecasts (2020-2031)
1.4 Global Dexamethasone Implant Sales Estimates and Forecasts (2020-2031)
1.5 Global Dexamethasone Implant Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Dexamethasone Implant Market Dynamics
2.1 Dexamethasone Implant Industry Trends
2.2 Dexamethasone Implant Industry Drivers
2.3 Dexamethasone Implant Industry Opportunities and Challenges
2.4 Dexamethasone Implant Industry Restraints
3 Dexamethasone Implant Market by Manufacturers
3.1 Global Dexamethasone Implant Revenue by Manufacturers (2020-2025)
3.2 Global Dexamethasone Implant Sales by Manufacturers (2020-2025)
3.3 Global Dexamethasone Implant Average Sales Price by Manufacturers (2020-2025)
3.4 Global Dexamethasone Implant Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Dexamethasone Implant Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Dexamethasone Implant Manufacturers, Product Type & Application
3.7 Global Dexamethasone Implant Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Dexamethasone Implant Market CR5 and HHI
3.8.2 Global Top 5 and 10 Dexamethasone Implant Players Market Share by Revenue in 2024
3.8.3 2024 Dexamethasone Implant Tier 1, Tier 2, and Tier 3
4 Dexamethasone Implant Market by Type
4.1 Dexamethasone Implant Type Introduction
4.1.1 0.7mg
4.1.2 0.35mg
4.2 Global Dexamethasone Implant Sales by Type
4.2.1 Global Dexamethasone Implant Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Dexamethasone Implant Sales by Type (2020-2031)
4.2.3 Global Dexamethasone Implant Sales Market Share by Type (2020-2031)
4.3 Global Dexamethasone Implant Revenue by Type
4.3.1 Global Dexamethasone Implant Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Dexamethasone Implant Revenue by Type (2020-2031)
4.3.3 Global Dexamethasone Implant Revenue Market Share by Type (2020-2031)
5 Dexamethasone Implant Market by Application
5.1 Dexamethasone Implant Application Introduction
5.1.1 Clinic
5.1.2 Hospital
5.1.3 Others
5.2 Global Dexamethasone Implant Sales by Application
5.2.1 Global Dexamethasone Implant Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Dexamethasone Implant Sales by Application (2020-2031)
5.2.3 Global Dexamethasone Implant Sales Market Share by Application (2020-2031)
5.3 Global Dexamethasone Implant Revenue by Application
5.3.1 Global Dexamethasone Implant Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Dexamethasone Implant Revenue by Application (2020-2031)
5.3.3 Global Dexamethasone Implant Revenue Market Share by Application (2020-2031)
6 Global Dexamethasone Implant Sales by Region
6.1 Global Dexamethasone Implant Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Dexamethasone Implant Sales by Region (2020-2031)
6.2.1 Global Dexamethasone Implant Sales by Region (2020-2025)
6.2.2 Global Dexamethasone Implant Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Dexamethasone Implant Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Dexamethasone Implant Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Dexamethasone Implant Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Dexamethasone Implant Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Dexamethasone Implant Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Dexamethasone Implant Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Dexamethasone Implant Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Dexamethasone Implant Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Dexamethasone Implant Revenue by Region
7.1 Global Dexamethasone Implant Revenue by Region
7.1.1 Global Dexamethasone Implant Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Dexamethasone Implant Revenue by Region (2020-2025)
7.1.3 Global Dexamethasone Implant Revenue by Region (2026-2031)
7.1.4 Global Dexamethasone Implant Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Dexamethasone Implant Revenue (2020-2031)
7.2.2 North America Dexamethasone Implant Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Dexamethasone Implant Revenue (2020-2031)
7.3.2 Europe Dexamethasone Implant Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Dexamethasone Implant Revenue (2020-2031)
7.4.2 Asia-Pacific Dexamethasone Implant Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Dexamethasone Implant Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Dexamethasone Implant Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 AbbVie
8.1.1 AbbVie Comapny Information
8.1.2 AbbVie Business Overview
8.1.3 AbbVie Dexamethasone Implant Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 AbbVie Dexamethasone Implant Product Portfolio
8.1.5 AbbVie Recent Developments
8.2 Curia
8.2.1 Curia Comapny Information
8.2.2 Curia Business Overview
8.2.3 Curia Dexamethasone Implant Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Curia Dexamethasone Implant Product Portfolio
8.2.5 Curia Recent Developments
8.3 EyePoint
8.3.1 EyePoint Comapny Information
8.3.2 EyePoint Business Overview
8.3.3 EyePoint Dexamethasone Implant Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 EyePoint Dexamethasone Implant Product Portfolio
8.3.5 EyePoint Recent Developments
8.4 Ocular Therapeutix
8.4.1 Ocular Therapeutix Comapny Information
8.4.2 Ocular Therapeutix Business Overview
8.4.3 Ocular Therapeutix Dexamethasone Implant Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Ocular Therapeutix Dexamethasone Implant Product Portfolio
8.4.5 Ocular Therapeutix Recent Developments
8.5 AffaMed Therapeutics
8.5.1 AffaMed Therapeutics Comapny Information
8.5.2 AffaMed Therapeutics Business Overview
8.5.3 AffaMed Therapeutics Dexamethasone Implant Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 AffaMed Therapeutics Dexamethasone Implant Product Portfolio
8.5.5 AffaMed Therapeutics Recent Developments
8.6 Ocumension Therapeutics
8.6.1 Ocumension Therapeutics Comapny Information
8.6.2 Ocumension Therapeutics Business Overview
8.6.3 Ocumension Therapeutics Dexamethasone Implant Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Ocumension Therapeutics Dexamethasone Implant Product Portfolio
8.6.5 Ocumension Therapeutics Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Dexamethasone Implant Value Chain Analysis
9.1.1 Dexamethasone Implant Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Dexamethasone Implant Production Mode & Process
9.2 Dexamethasone Implant Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Dexamethasone Implant Distributors
9.2.3 Dexamethasone Implant Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.